Drug intelligence / Profile preview

carotenoid nanoemulsion

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Carotenoid nanoemulsion is a stable formulation prepared from pomelo leaves (Citrus grandis Osbeck) containing fourteen identified carotenoids, including all-trans-lutein, all-trans-neoxanthin, all-trans-violaxanthin, all-trans-β-carotene, all-trans-α-carotene, all-trans-zeaxanthin, and all-trans-β-cryptoxanthin. This nanoemulsion has a mean particle size of 13.3 nm and an encapsulation efficiency of 99%. It has demonstrated inhibitory effects on melanoma A375 cells by upregulating tumor suppressor proteins (p53, p21) and cell cycle regulators (cyclin B, cyclin A), while downregulating cyclin-dependent kinases (CDK1, CDK2). Furthermore, it promotes apoptosis by upregulating pro-apoptotic proteins (Bax, cytochrome-C), downregulating anti-apoptotic protein (Bcl-2), and activating caspases (caspase-9, caspase-8, caspase-3). The carotenoid nanoemulsion has shown greater efficacy in inhibiting melanoma cell growth compared to the carotenoid extract alone, indicating its potential as a functional food or botanic drug.

02

Targets

CCNB1 (Cyclin B1)TP53 (Cellular Tumor Antigen p53 R175H)CCNA2 (Cyclin A2)CDKN1A (Cyclin-dependent kinase inhibitor 1A)CDK2 (Cyclin-dependent kinase 2)CDK1 (Cyclin-dependent kinase 1)CASP3 (Caspase-3)CYCS (Cytochrome c)CASP9 (Caspase-9)CASP8 (Caspase-8)BAX (Apoptosis regulator BAX)

Beyond the preview

Go deeper on carotenoid nanoemulsion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carotenoid nanoemulsion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call